In a press release, Dendreon said that the FDA wants more data from clinical trials, but that the company needsclarification on exactly what it needs to do.
Robin Bhar, senior metals strategist with Credit Agricole CIB, suggested the market needs further clarification to draw definitive conclusions, such as whether the 1.9-million-ton figure includes working stockpiles and strategic reserves.